drugset / Trial / NCT05232123

Cannabidiol Effects on Cardiovascular System and Exercise Responses

NCT05232123

Phase 0 Withdrawn Castleton University
RandomizedCrossoverTriple-blindBasic science

Summary

To identify the autonomic effects of recreationally-relevant doses of cannabidiol (CBD) in an older population, and to evaluate the effect of CBD on exercise performance and recovery.

Timeline

Start
2023-07
Primary completion
2024-12
Completion
2024-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabidiol Other / unclassified 25 mg Oral
Subject Cannabidiol Other / unclassified 50 mg Oral
Subject Cannabidiol Other / unclassified 200 mg Oral

Indications

No indication recorded.